Las Palmas de Gran Canaria, March 25, 2025. Hospiten Roca, through its Urology Unit, incorporates the Tulium (Thulium) laser in urological surgery focused on pathologies of the genitourinary system in men and the urinary system in women. It is an advanced technology that emits a wavelength of 1940 nm, optimal for water absorption, allowing a precise cut and effective coagulation in soft tissues, offering great benefits for patients.
The specialist in Urology, Dr. Barroso Deyne, explains that this new technology increases the safety of the intervention, and decreases the recovery time and side effects of the surgery with respect to previous techniques, since the action of this new tool is based on the vaporization and controlled dissection of the tissue with minimal thermal damage to the surrounding tissues. "The Tulio laser is especially indicated in cases of large-volume prostates, patients with anticoagulation that cannot be easily suspended, and in those in which postoperative complications are sought to be minimized," he points out.
Thulium is highly versatile and can be used in "multiple urological pathologies, such as: Benign Prostatic Hyperplasia (BPH) for prostatic enucleation (ThuLEP), which is particularly effective in prostates of any size; urinary lithiasis used to fragment and vaporize stones in any location of the urinary tract; soft tissue lesions such as resection of superficial bladder tumors; and in internal urethrotomy procedures of urethral strictures."
Regarding the main advantages that can be obtained with the Tulium laser in comparison with traditional surgical methods or any alternative treatment, the specialist points out that there are five positive aspects. Among them, he highlights the surgical precision that allows precise dissection with superior control of hemostasis, as well as the versatility that can be used for vaporization, enucleation and stone treatment, which makes it an integral tool. "Compared to open surgery or some traditional procedures, it reduces postoperative morbidity, being less invasive," he notes.
"It is also important to mention that bleeding is decreased, which is ideal for patients at high risk of bleeding, such as those on anticoagulant treatment. The shorter hospitalization time and early return to daily activities are also advantages of this tool," he adds.
About Hospiten
Hospiten is an international healthcare network with more than 55 years of experience committed to providing the highest quality service, with 20 private medical-hospital centers in Spain, the Dominican Republic, Mexico, Jamaica and Panama, in addition to 175 outpatient medical centers, under the Clinic Assist brand. Founded by Dr. Pedro Luis Cobiella, it annually attends more than two million patients from all over the world and has a staff of more than 5,000 people, a number that will be reinforced in the Community of Madrid thanks to the construction of a general university hospital in Boadilla del Monte, which is expected to be completed in 2026.
MD Anderson Cancer Center Madrid - Hospiten is a subsidiary of the prestigious MD Anderson Cancer Center in Houston (Texas, USA). With more than 20 years of history in Spain, MD Anderson Madrid - Hospiten currently has a Phase I Clinical Trials Unit, more than 150 medical specialists trained in oncology, a total of 87 hospital beds and state-of-the-art technological equipment for the diagnosis and treatment of different types of cancer.
This article is an English translation generated with AI from the original Spanish content. While we review content for clarity, the information is provided for general informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional for diagnosis or treatment.